{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-105533","form_type":"8-K","ticker":"DMRA","cik":"0001800315","company_name":"Damora Therapeutics, Inc.","filed_at":"2024-09-11T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.558873+00:00","generated_at":"2026-05-31T05:28:32.960496+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Galecto completes 1-for-25 reverse stock split; post-split shares at 1,248,266","bullets":["Reverse stock split effective August 29, 2024; every 25 shares converted to 1 share.","Computershare confirms total outstanding shares post-split: 1,248,266.","Fractional shares resulting from the reverse split were rounded up to the nearest whole share."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-105533","json":"https://secwatch.observer/filing/0000950170-24-105533.json","markdown":"https://secwatch.observer/filing/0000950170-24-105533.md","text":"https://secwatch.observer/filing/0000950170-24-105533.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024105533/0000950170-24-105533-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1800315/000095017024105533/glto-20240910.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:28:32.960496+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}